Urinary albumin-to-creatinine ratio and eGFR should be measured at least once per year in patients with low and moderate CKD risk, which include G1A1, G2A1 (green) and G1A2, G2A2, G3aA1 (yellow) [9]. This evidence concerns the gene ALB and chronic kidney disease.